International Value Advisers Decreased By $49.11 Million Its Ralph Lauren Corp. (RL) Position; Dare Bioscience (DARE) Shorts Down By 2.32%

February 16, 2018 - By Adrian Mccoy

International Value Advisers Llc decreased Ralph Lauren Corp. (RL) stake by 55.15% reported in 2017Q3 SEC filing. International Value Advisers Llc sold 558,024 shares as Ralph Lauren Corp. (RL)’s stock declined 11.61%. The International Value Advisers Llc holds 453,895 shares with $40.07 million value, down from 1.01M last quarter. Ralph Lauren Corp. now has $8.63B valuation. The stock decreased 0.71% or $0.76 during the last trading session, reaching $106.19. About 249,347 shares traded. Ralph Lauren Corporation (NYSE:RL) has declined 22.29% since February 16, 2017 and is downtrending. It has underperformed by 38.99% the S&P500.

Dare Bioscience Incorporated (NASDAQ:DARE) had a decrease of 2.32% in short interest. DARE’s SI was 172,800 shares in February as released by FINRA. Its down 2.32% from 176,900 shares previously. With 68,700 avg volume, 3 days are for Dare Bioscience Incorporated (NASDAQ:DARE)’s short sellers to cover DARE’s short positions. The stock decreased 3.57% or $0.05 during the last trading session, reaching $1.35. About 527,072 shares traded or 89.15% up from the average. Daré Bioscience, Inc. (NASDAQ:DARE) has 0.00% since February 16, 2017 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment increased to 1.05 in 2017 Q3. Its up 0.01, from 1.04 in 2017Q2. It improved, as 40 investors sold RL shares while 111 reduced holdings. 59 funds opened positions while 100 raised stakes. 52.86 million shares or 5.79% more from 49.97 million shares in 2017Q2 were reported. Jacobs Levy Equity Management stated it has 32,821 shares. Schroder Invest Mngmt owns 0.02% invested in Ralph Lauren Corporation (NYSE:RL) for 99,976 shares. Mufg Americas Corporation reported 0% stake. Sunbelt Securities holds 1.47% of its portfolio in Ralph Lauren Corporation (NYSE:RL) for 15,856 shares. Systematic Finance Mgmt LP reported 16,685 shares. Canada Pension Plan Board stated it has 188,807 shares. Ls Invest Ltd Liability has invested 0.02% in Ralph Lauren Corporation (NYSE:RL). Ing Groep Nv invested in 0.01% or 6,336 shares. Raymond James & Associates has 3,677 shares. Price T Rowe Associate Md holds 0.02% in Ralph Lauren Corporation (NYSE:RL) or 1.49M shares. Capital Fund Mgmt holds 22,602 shares or 0.01% of its portfolio. Texas Permanent School Fund has 15,348 shares for 0.02% of their portfolio. Bnp Paribas Asset Mngmt Holdings holds 0.03% or 39,525 shares. Delta Asset Mngmt Limited Liability Tn invested in 25 shares or 0% of the stock. Moreover, Sequoia Fin Advsrs Ltd Co has 0.02% invested in Ralph Lauren Corporation (NYSE:RL) for 2,364 shares.

Among 29 analysts covering Polo Ralph Lauren Corporation (NYSE:RL), 9 have Buy rating, 5 Sell and 15 Hold. Therefore 31% are positive. Polo Ralph Lauren Corporation had 83 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Ralph Lauren Corporation (NYSE:RL) has “Neutral” rating given on Wednesday, September 13 by Buckingham Research. The firm has “Hold” rating by Cowen & Co given on Wednesday, November 1. The stock of Ralph Lauren Corporation (NYSE:RL) earned “Outperform” rating by Telsey Advisory Group on Friday, November 6. The firm earned “Hold” rating on Thursday, August 6 by Cowen & Co. As per Wednesday, February 1, the company rating was downgraded by Evercore. The firm has “Sell” rating by Piper Jaffray given on Thursday, July 13. UBS maintained the stock with “Buy” rating in Wednesday, May 11 report. CLSA downgraded Ralph Lauren Corporation (NYSE:RL) on Friday, February 3 to “Outperform” rating. On Thursday, November 16 the stock rating was maintained by Cowen & Co with “Hold”. The stock of Ralph Lauren Corporation (NYSE:RL) earned “Neutral” rating by Credit Suisse on Wednesday, June 8.

Daré Bioscience, Inc. develops and commercializes product for women’s reproductive health, Ovaprene. The company has market cap of $15.93 million.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>